Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study

Bibliographic Details
Title:	Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study
Authors:	Miri, Syna ¹, Rosendaal, Frits R. ², Kavakli, Kaan ³, Eshghi, Peyman ⁴, Moghaddam, Soha Mohammadi ⁴, Scardo, Sara ¹, Habibpanah, Behnaz ⁴, Elalfy, Mohsen ⁵, Halimeh, Susan ⁶, Nicolò, Gabriella ⁷, Gökçebay, Dilek ⁸, Özbek, Namık ⁸, Celkan, Tiraje ⁹, Mohammadi, Ahmad ¹⁰, Karimi, Mehran ^{11, 12}, Shahsavani, Amin ¹², Yılmaz, Bariş ¹³, Albayrak, Canan ¹⁴, Gunes, Burcak ¹⁵, Kaya, Zühre ¹⁶, Ay, Yilmaz ¹⁷, Akbayram, Sinan ¹⁸, Sarper, Nazan ¹⁹, Mannucci, Pier Mannuccio ¹, Peyvandi, Flora ^{1, 20, ∗}
Source:	In Research and Practice in Thrombosis and Haemostasis November 2024 8(8)
Database:	ScienceDirect

More Details
ISSN:	24750379
DOI:	10.1016/j.rpth.2024.102595
Published in:	Research and Practice in Thrombosis and Haemostasis
Language:	English